Immuron CSO discloses initial share holdings

Immuron Ltd Chief Scientific Officer Jerry Kanellos filed an initial ownership report showing his existing equity position.

Rhea-AI Filing Summary

Immuron Ltd Chief Scientific Officer Jerry Kanellos filed an initial ownership report showing his existing equity position. He directly holds 333,000 Ordinary Shares of Immuron.

He also holds Performance Rights over 272,134 underlying Ordinary Shares with a 0.0000 exercise price expiring on June 30, 2029, and additional Performance Rights over 179,664 underlying Ordinary Shares with a 0.0000 exercise price expiring on July 12, 2027. A footnote states these Performance Rights became exercisable as to 217,707 shares on July 23, 2025 and 54,427 shares on October 29, 2025.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Kanellos Jerry

Role Chief Scientific Officer

Type	Security	Shares	Price	Value
holding	Performance Rights	--	--	--
holding	Performance Rights	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Performance Rights — 451,798 contracts (Direct); Ordinary Shares — 333,000 shares (Direct)

Footnotes (1)

1. F1. The Performance Rights became exercisable as to 217,707 shares on July 23, 2025 and 54,427 shares on October 29, 2025.

Key Figures

Direct Ordinary Shares: 333,000 shares Performance Rights 2029: 272,134 underlying shares Performance Rights 2027: 179,664 underlying shares +3 more

6 metrics

Direct Ordinary Shares 333,000 shares Directly held Ordinary Shares reported on Form 3

Performance Rights 2029 272,134 underlying shares Performance Rights, exercise price 0.0000, expire June 30, 2029

Performance Rights 2027 179,664 underlying shares Performance Rights, exercise price 0.0000, expire July 12, 2027

Exercise price 0.0000 per share Stated exercise price for reported Performance Rights

Exercisable tranche 217,707 shares Performance Rights became exercisable on July 23, 2025

Second exercisable tranche 54,427 shares Performance Rights became exercisable on October 29, 2025

Key Terms

Performance Rights, Ordinary Shares, exercise price, expiration date

4 terms

Performance Rights financial

"The Performance Rights became exercisable as to 217,707 shares on July 23, 2025"

Performance rights are conditional awards that give employees or executives the promise of receiving company shares or cash only if the business meets specific targets or survives for a set period. They work like a bonus you only get when certain goals are hit, so they matter to investors because they can increase the number of shares outstanding (dilution), signal management’s incentives and confidence in future results, and affect per-share earnings and valuation.

Ordinary Shares financial

"security_title: "Ordinary Shares" and underlying_security_title: "Ordinary Shares""

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

exercise price financial

"conversion_or_exercise_price: "0.0000" for the Performance Rights"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date: "2029-06-30T00:00:00.000Z" and "2027-07-12T00:00:00.000Z""

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Immuron (IMRN) Chief Scientific Officer Jerry Kanellos report on this Form 3?

He reports his existing equity holdings in Immuron. The filing shows 333,000 Ordinary Shares held directly plus significant Performance Rights over additional Ordinary Shares, establishing his baseline ownership as an officer.

How many Immuron (IMRN) Ordinary Shares does Jerry Kanellos directly own?

He directly owns 333,000 Ordinary Shares of Immuron Ltd. This figure represents his current direct shareholding reported in the Form 3 and serves as a reference point for any future insider transactions.

What Performance Rights over Immuron (IMRN) shares does Jerry Kanellos hold?

He holds Performance Rights over 272,134 underlying Ordinary Shares expiring on June 30, 2029 and 179,664 underlying Ordinary Shares expiring on July 12, 2027, each with a stated 0.0000 exercise price.

When do Jerry Kanellos’ Immuron (IMRN) Performance Rights become exercisable?

A footnote states the Performance Rights became exercisable as to 217,707 shares on July 23, 2025 and 54,427 shares on October 29, 2025. These dates indicate when specific tranches of rights could first be exercised.

Does this Immuron (IMRN) Form 3 show any insider buying or selling?

No buy or sell activity is shown; it records holdings only. The transactions are classified as holdings with unknown transaction codes, providing a snapshot of existing ownership rather than new trades.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/29/2026 - 04:01 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Kanellos Jerry

(Last) (First) (Middle)

LEVEL 3, 62 LYGON STREET

(Street)

CARLTON VIC 3053

(City) (State) (Zip)

AUSTRALIA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Immuron Ltd [ IMRN ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Scientific Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	333,000	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Rights	07/12/2023	07/12/2027	Ordinary Shares	179,664	$0	D
Performance Rights	10/24/2024(1)	06/30/2029	Ordinary Shares	272,134	$0	D

Explanation of Responses:

1. The Performance Rights became exercisable as to 217,707 shares on July 23, 2025 and 54,427 shares on October 29, 2025.

	/s/ Jerry Kanellos	04/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)